IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
Sven H. Loosen(Düsseldorf University Hospital), Tom Luedde(Düsseldorf University Hospital), Catherine Leyh(Düsseldorf University Hospital), Christoph Roderburg(Düsseldorf University Hospital), Fabian Benz(RWTH Aachen University), Maximilian Schulze‐Hagen(Universitätsklinikum Aachen), Philipp Bruners(RWTH Aachen University), Christiane Kühl(Universitätsklinikum Aachen), Mihael Vucur(Düsseldorf University Hospital), Frank Tacke(Charité - Universitätsmedizin Berlin), Christian Trautwein(TUM Klinikum)
Cited by 51
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
|Nature Reviews Gastroenterology & Hepatology|2011|1.4k
Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer
|Journal of Clinical Oncology|2005|1.1k